Twist Bioscience (TWST) Other financing activities (2017 - 2026)

Twist Bioscience (TWST) has reported Other financing activities for 10 consecutive years, with $3.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other financing activities rose 107.38% year-over-year to $3.8 million in Q2 2026; TTM through Jun 2026 was $9.7 million, a 29.54% increase from a year earlier, with the FY2025 full-year figure at $9.3 million, up 31.59% from the prior year.
• Other financing activities was $3.8 million for Q2 2026 at Twist Bioscience, up from $1.8 million in the prior quarter.
• Over five years, Other financing activities peaked at $266.7 million in Q1 2022 and troughed at -$2000.0 in Q3 2022.
• A 5-year average of $16.1 million and a median of $1.1 million in 2023 frame the typical range for Other financing activities.
• The widest YoY moves for Other financing activities: up 8650.0% in 2023, down 99.91% in 2023.
• Over 5 years, Other financing activities stood at $604000.0 in 2022, then surged by 57.45% to $951000.0 in 2023, then surged by 210.2% to $2.9 million in 2024, then tumbled by 89.83% to $300000.0 in 2025, then surged by 1164.33% to $3.8 million in 2026.
• The last three Other financing activities figures came in at $3.8 million (Q2 2026), $1.8 million (Q1 2026), and $300000.0 (Q4 2025), per Business Quant data.